Additionally, within high-grade gliomas (WHO III and IV), IL13Rα2 expression also increases with malignancy grade, with a 2.5-fold increase for WHO grade IV versus grade III tumors (p=2.9 x 10-8). The gene discussed is IL13RA2; the disease is glioma.